by KeyaMedical | Jan 14, 2021 | All News, Investors, Press
Keya Medical has raised $46 million in Series D funding. This funding round was led by new and existing investors, including CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, and IN CAPITAL.
by KeyaMedical | Nov 12, 2020 | All News, Investors, Press
Keya Medical announced that it has completed a $30 Million Series C Funding Round led by IDG Capital, with participation from investors Alwin Capital, Source Code Capital, and Tasly Group.
by KeyaMedical | Aug 23, 2020 | Investors, Press
Keya Medical announced on Aug. 13 that it has raised over $20 million in Series B+ funding.
by KeyaMedical | Feb 19, 2020 | Investors, Press
Keya Medical announced today that it has received a strategic investment from Kunlun Wanwei Group, IDG Capital, Shanghai Guofang Parent Fund, and Yahui Capital.
by KeyaMedical | Jan 22, 2020 | Investors, Press
On January 15, 2020, the National Medical Products Administration in China issued the registration certificate approving DeepVessel FFR for clinical use.
Recent Comments